Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease
Authors
Keywords
-
Journal
Current Atherosclerosis Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-04
DOI
10.1007/s11883-022-01027-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
- (2021) Pichamol Jirapinyo et al. Clinical Gastroenterology and Hepatology
- The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
- (2021) Manal F. Abdelmalek et al. Contemporary Clinical Trials
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis
- (2021) Chloe Wong et al. Frontiers in Endocrinology
- Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double‐Blind Phase 2 Trial
- (2021) Samer Gawrieh et al. HEPATOLOGY
- Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis
- (2021) Federico Salomone et al. LIVER INTERNATIONAL
- Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
- (2021) Chloe Wong et al. Frontiers in Endocrinology
- A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Non-alcoholic Fatty Liver Disease
- (2021) Jonathan Zhi Kai Toh et al. Clinical Gastroenterology and Hepatology
- A clinical overview of non‐alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications—What the non‐specialist needs to know
- (2021) Mark D. Muthiah et al. DIABETES OBESITY & METABOLISM
- TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
- (2021) Rohit Loomba et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
- (2021) Jieling Xiao et al. Frontiers in Medicine
- Trends in statin utilisation in US adults with non‐alcoholic fatty liver disease
- (2021) Jacqueline B. Henson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials
- (2021) Cheng Han Ng et al. Endocrine Practice
- Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
- (2021) Ali Aminian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
- (2020) K.J. Lucas et al. DIGESTIVE AND LIVER DISEASE
- Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis
- (2020) Cristy R.C. Verzijl et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Burden of Disease due to Nonalcoholic Fatty Liver Disease
- (2020) Mark D. Muthiah et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Current management of non‐alcoholic steatohepatitis
- (2020) Mark D. Muthiah et al. LIVER INTERNATIONAL
- Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
- (2020) Jean-François Dufour et al. GUT
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: an updated meta-analysis
- (2019) Alessandro Mantovani et al. LIVER INTERNATIONAL
- Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events
- (2019) Sean L. Zheng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity
- (2019) Maria J. Pereira et al. DRUGS
- Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease
- (2019) Tracey G. Simon et al. Clinical Gastroenterology and Hepatology
- Incretin‐Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
- (2019) Kenneth Cusi HEPATOLOGY
- Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
- (2019) Philip Newsome et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
- (2019) Dimitrios A. Koutoukidis et al. JAMA Internal Medicine
- Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
- (2019) Stefania Kiapidou et al. Annals of Hepatology
- Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
- (2019) M.S. Capehorn et al. DIABETES & METABOLISM
- CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
- (2019) Paul J. Pockros et al. LIVER INTERNATIONAL
- Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists
- (2019) Rohit A. Sinha et al. THYROID
- Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
- (2019) Marcos Pedrosa et al. Contemporary Clinical Trials
- MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
- (2019) Michael A Nauck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy
- (2019) Xinyang Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
- (2019) Naga Chalasani et al. GASTROENTEROLOGY
- A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
- (2019) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Significant improvement in cardiometabolic health in healthy nonobese individuals during caloric restriction-induced weight loss and weight loss maintenance
- (2018) Jasper Most et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
- (2018) Fernando Bril et al. Clinical Gastroenterology and Hepatology
- Treatment of Dyslipidemia in Common Liver Diseases
- (2018) Elizabeth K. Speliotes et al. Clinical Gastroenterology and Hepatology
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
- (2018) Filippo Valbusa et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Direct effects of thyroid hormones on hepatic lipid metabolism
- (2018) Rohit A. Sinha et al. Nature Reviews Endocrinology
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
- (2018) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition
- (2018) Debapriya Basu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- Prevalence and Severity of Nonalcoholic Fatty Liver Disease (NAFLD) Among Caregivers of Patients with NAFLD Cirrhosis
- (2018) Mohammad Shadab Siddiqui et al. Clinical Gastroenterology and Hepatology
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
- (2018) Frank L. Greenway et al. Obesity
- Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study
- (2018) Edgar D. Charles et al. Obesity
- Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding
- (2018) Paul E. O’Brien et al. OBESITY SURGERY
- Risk of Suicide and Self-harm Is Increased After Bariatric Surgery—a Systematic Review and Meta-analysis
- (2018) Daniel Castaneda et al. OBESITY SURGERY
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease
- (2017) Giovanni Targher et al. Nature Reviews Nephrology
- Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity
- (2017) Sevda Karimian et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
- (2017) Filippo Valbusa et al. PLoS One
- Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults
- (2017) Sean Chun-Chang Chen et al. Scientific Reports
- Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
- (2016) Z. Gordon Jiang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population
- (2016) Marcello Ricardo Paulista Markus et al. ATHEROSCLEROSIS
- Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring
- (2016) Alessandro Mantovani et al. DIABETES CARE
- A “systems medicine” approach to the study of non-alcoholic fatty liver disease
- (2016) Salvatore Petta et al. DIGESTIVE AND LIVER DISEASE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Management of obesity
- (2016) George A Bray et al. LANCET
- Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
- (2016) Filippo Valbusa et al. MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic fatty liver disease - A multisystem disease?
- (2016) Ivana Mikolasevic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
- (2015) Rotonya M. Carr et al. Current Atherosclerosis Reports
- Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia
- (2015) Pierre Blais et al. DIGESTIVE DISEASES AND SCIENCES
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Effect of aerobic exercise training dose on liver fat and visceral adiposity
- (2015) Shelley E. Keating et al. JOURNAL OF HEPATOLOGY
- Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
- (2015) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk
- (2015) Ehimen C. Aneni et al. JOURNAL OF HYPERTENSION
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Effect of Weight Loss Induced by Intragastric Balloon Therapy on Cardiac Function in Morbidly Obese Individuals: A Pilot Study
- (2015) Fatih Koc et al. MEDICAL PRINCIPLES AND PRACTICE
- Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
- (2015) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Republished: Non-alcoholic fatty liver disease: a practical approach to treatment
- (2015) J K Dyson et al. POSTGRADUATE MEDICAL JOURNAL
- Impact of obesity on cardiac metabolism, fibrosis, and function
- (2015) Rajiv Mahajan et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome
- (2015) Konstantinos Kargiotis WORLD JOURNAL OF GASTROENTEROLOGY
- Practice patterns in NAFLD and NASH: real life differs from published guidelines
- (2015) Mary E. Rinella et al. Therapeutic Advances in Gastroenterology
- Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis
- (2014) Lisa M. Glass et al. DIGESTIVE DISEASES AND SCIENCES
- Clinical association between non-alcoholic fatty liver disease and the development of hypertension
- (2014) Jae-Hong Ryoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Lifestyle-Induced Decrease in Fat Mass Improves Adiponectin Secretion in Obese Adults
- (2014) KAREN R. KELLY et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Enhancing the role of nutrition professionals in weight management: A cross-sectional survey
- (2014) Sara N. Bleich et al. Obesity
- Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
- (2014) Stefano Bonapace et al. PLoS One
- Ventricular remodelling post-bariatric surgery: is the type of surgery relevant? A prospective study with 3D speckle tracking
- (2014) T. E. Kaier et al. European Heart Journal-Cardiovascular Imaging
- Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding
- (2013) Laura Folini et al. ACTA DIABETOLOGICA
- Hepatic Steatosis Is Associated With Aortic Valve Sclerosis in the General Population
- (2013) Marcello Ricardo Paulista Markus et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- (2013) Ebenezer T. Oni et al. ATHEROSCLEROSIS
- The Addictive Dimensionality of Obesity
- (2013) Nora D. Volkow et al. BIOLOGICAL PSYCHIATRY
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2013) Maria Stepanova et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause Mortality
- (2013) James H. O'Keefe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Blood alcohol concentrations rise rapidly and dramatically after Roux-en-Y gastric bypass
- (2013) Kristine J. Steffen et al. Surgery for Obesity and Related Diseases
- Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
- (2012) G. Musso et al. DIABETOLOGIA
- Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
- (2012) Yin-Mei Lee et al. GASTROINTESTINAL ENDOSCOPY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
- (2012) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy
- (2012) Rohit Anthony Sinha et al. JOURNAL OF CLINICAL INVESTIGATION
- Psychological dimensions after laparoscopic sleeve gastrectomy: reduced mental burden, improved eating behavior, and ongoing need for cognitive eating control
- (2012) Nicole Rieber et al. Surgery for Obesity and Related Diseases
- Effect of Bariatric Surgery on Cardiovascular Risk Profile†Drs. Heneghan and Meron-Eldar contributed equally to this article.
- (2011) Helen M. Heneghan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
- (2011) W. Nseir et al. DIGESTIVE DISEASES AND SCIENCES
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
- (2011) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Favorable Changes in Cardiac Geometry and Function Following Gastric Bypass Surgery
- (2011) Theophilus Owan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Diet and Exercise, Alone or Combined, on Weight and Body Composition in Overweight-to-Obese Postmenopausal Women
- (2011) Karen E. Foster-Schubert et al. Obesity
- Molecular mechanisms involved in hepatic steatosis and insulin resistance
- (2011) Takashi Matsuzaka et al. Journal of Diabetes Investigation
- A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease
- (2010) Giovanni Musso et al. HEPATOLOGY
- Acute stress reaction and completed suicide
- (2010) J. L. Gradus et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype
- (2010) Shany Blum et al. PHARMACOGENOMICS
- Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
- (2009) Cecilia Söderberg et al. HEPATOLOGY
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Health Outcomes of Gastric Bypass Patients Compared to Nonsurgical, Nonintervened Severely Obese
- (2009) Ted D. Adams et al. Obesity
- Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
- (2009) Eugen Florin Georgescu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
- (2008) Nila Rafiq et al. Clinical Gastroenterology and Hepatology
- High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease
- (2008) K Kantartzis et al. GUT
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bariatric Surgery: Risks and Rewards
- (2008) Walter J. Pories JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
- (2008) James L. Rosenzweig et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype
- (2007) Uzi Milman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
- (2007) L. Spadaro et al. DIGESTIVE AND LIVER DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search